Concepedia
Publication | Open Access
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
91
Citations
35
References
2023
Year
Page 1